Related Content
March 3, 2014 — OrbusNeich announced that patient enrollment has initiated in Japan in the pivotal clinical trial of the ...
October 29, 2013 — OrbusNeich announced the publication of a study demonstrating that lesion preparation with the ...
September 20, 2013 – OrbusNeich Medical Inc. and Boston Scientific Corp. have settled all stent-related litigation ...
August 16, 2013 — Patient enrollment has been initiated in a post-market registry for the Combo Dual Therapy Stent to ...
June 3, 2013 — OrbusNeich has launched the world's first dual-therapy stent to address the challenges of delayed healing ...
February 28, 2013 — OrbusNeich announced that OrbusNeich Medical GmbH has commenced patent infringement actions in ...
November 14, 2011 – OrbusNeich announced the introduction of the Combo dual therapy stent during a breakfast symposium ...
August 17, 2011 — OrbusNeich announced its Genous stent showed no significant difference in target vessel failure (TVF) ...
July 18, 2011 — OrbusNeich announced that data from an ex vivo arteriovenous (AV) shunt model of human circulating blood ...
May 23, 2011 - OrbusNeich announced that data from multiple clinical trials supporting the safety and efficacy of the ...